nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2B6—malignant glioma	0.851	1	CbGaD
Amprenavir—CYP3A4—Temozolomide—malignant glioma	0.0139	1	CbGbCtD
Amprenavir—Opportunistic infection—Temozolomide—malignant glioma	0.00313	0.0883	CcSEcCtD
Amprenavir—Transaminases increased—Carmustine—malignant glioma	0.00215	0.0605	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00139	0.0391	CcSEcCtD
Amprenavir—Diabetes mellitus—Carmustine—malignant glioma	0.00109	0.0307	CcSEcCtD
Amprenavir—Liver function test abnormal—Carmustine—malignant glioma	0.000875	0.0247	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000825	0.0232	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000808	0.0228	CcSEcCtD
Amprenavir—Neutropenia—Carmustine—malignant glioma	0.000766	0.0216	CcSEcCtD
Amprenavir—Neutropenia—Temozolomide—malignant glioma	0.000741	0.0209	CcSEcCtD
Amprenavir—Hyperglycaemia—Carmustine—malignant glioma	0.000739	0.0208	CcSEcCtD
Amprenavir—Depression—Carmustine—malignant glioma	0.000729	0.0205	CcSEcCtD
Amprenavir—Hyperglycaemia—Temozolomide—malignant glioma	0.000714	0.0201	CcSEcCtD
Amprenavir—Depression—Temozolomide—malignant glioma	0.000704	0.0198	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0007	0.0197	CcSEcCtD
Amprenavir—Hepatobiliary disease—Temozolomide—malignant glioma	0.000668	0.0188	CcSEcCtD
Amprenavir—Connective tissue disorder—Carmustine—malignant glioma	0.000645	0.0182	CcSEcCtD
Amprenavir—Connective tissue disorder—Temozolomide—malignant glioma	0.000623	0.0175	CcSEcCtD
Amprenavir—Erythema multiforme—Temozolomide—malignant glioma	0.000599	0.0169	CcSEcCtD
Amprenavir—Cardiac disorder—Temozolomide—malignant glioma	0.000588	0.0166	CcSEcCtD
Amprenavir—Mental disorder—Carmustine—malignant glioma	0.000575	0.0162	CcSEcCtD
Amprenavir—Malnutrition—Carmustine—malignant glioma	0.000571	0.0161	CcSEcCtD
Amprenavir—Mental disorder—Temozolomide—malignant glioma	0.000555	0.0156	CcSEcCtD
Amprenavir—Malnutrition—Temozolomide—malignant glioma	0.000552	0.0155	CcSEcCtD
Amprenavir—Tremor—Carmustine—malignant glioma	0.000535	0.0151	CcSEcCtD
Amprenavir—Tremor—Temozolomide—malignant glioma	0.000517	0.0146	CcSEcCtD
Amprenavir—Angioedema—Temozolomide—malignant glioma	0.000504	0.0142	CcSEcCtD
Amprenavir—Myalgia—Carmustine—malignant glioma	0.000486	0.0137	CcSEcCtD
Amprenavir—Myalgia—Temozolomide—malignant glioma	0.00047	0.0132	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000467	0.0131	CcSEcCtD
Amprenavir—Discomfort—Temozolomide—malignant glioma	0.000464	0.0131	CcSEcCtD
Amprenavir—Anorexia—Carmustine—malignant glioma	0.000444	0.0125	CcSEcCtD
Amprenavir—Nervous system disorder—Temozolomide—malignant glioma	0.000442	0.0124	CcSEcCtD
Amprenavir—Skin disorder—Temozolomide—malignant glioma	0.000437	0.0123	CcSEcCtD
Amprenavir—Anorexia—Temozolomide—malignant glioma	0.000429	0.0121	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000425	0.012	CcSEcCtD
Amprenavir—Paraesthesia—Carmustine—malignant glioma	0.000418	0.0118	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00041	0.0116	CcSEcCtD
Amprenavir—Decreased appetite—Carmustine—malignant glioma	0.000405	0.0114	CcSEcCtD
Amprenavir—Paraesthesia—Temozolomide—malignant glioma	0.000404	0.0114	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Carmustine—malignant glioma	0.000402	0.0113	CcSEcCtD
Amprenavir—Decreased appetite—Temozolomide—malignant glioma	0.000391	0.011	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000389	0.011	CcSEcCtD
Amprenavir—Fatigue—Temozolomide—malignant glioma	0.000388	0.0109	CcSEcCtD
Amprenavir—Gastrointestinal pain—Carmustine—malignant glioma	0.000381	0.0107	CcSEcCtD
Amprenavir—Abdominal pain—Carmustine—malignant glioma	0.000368	0.0104	CcSEcCtD
Amprenavir—Gastrointestinal pain—Temozolomide—malignant glioma	0.000368	0.0104	CcSEcCtD
Amprenavir—Abdominal pain—Temozolomide—malignant glioma	0.000356	0.01	CcSEcCtD
Amprenavir—Asthenia—Carmustine—malignant glioma	0.000334	0.00942	CcSEcCtD
Amprenavir—Asthenia—Temozolomide—malignant glioma	0.000323	0.0091	CcSEcCtD
Amprenavir—Diarrhoea—Carmustine—malignant glioma	0.000319	0.00898	CcSEcCtD
Amprenavir—Pruritus—Temozolomide—malignant glioma	0.000319	0.00898	CcSEcCtD
Amprenavir—Diarrhoea—Temozolomide—malignant glioma	0.000308	0.00868	CcSEcCtD
Amprenavir—Vomiting—Carmustine—malignant glioma	0.000296	0.00835	CcSEcCtD
Amprenavir—Rash—Carmustine—malignant glioma	0.000294	0.00828	CcSEcCtD
Amprenavir—Dermatitis—Carmustine—malignant glioma	0.000294	0.00827	CcSEcCtD
Amprenavir—Headache—Carmustine—malignant glioma	0.000292	0.00822	CcSEcCtD
Amprenavir—Vomiting—Temozolomide—malignant glioma	0.000286	0.00807	CcSEcCtD
Amprenavir—Rash—Temozolomide—malignant glioma	0.000284	0.008	CcSEcCtD
Amprenavir—Dermatitis—Temozolomide—malignant glioma	0.000284	0.00799	CcSEcCtD
Amprenavir—Headache—Temozolomide—malignant glioma	0.000282	0.00795	CcSEcCtD
Amprenavir—Nausea—Carmustine—malignant glioma	0.000277	0.0078	CcSEcCtD
Amprenavir—Nausea—Temozolomide—malignant glioma	0.000267	0.00754	CcSEcCtD
Amprenavir—CYP2B6—Metabolism—SPHK1—malignant glioma	3.05e-05	0.000305	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.05e-05	0.000305	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.02e-05	0.000302	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN2B—malignant glioma	3e-05	0.000301	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3e-05	0.0003	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.99e-05	0.000299	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SPHK1—malignant glioma	2.98e-05	0.000298	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.97e-05	0.000297	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.93e-05	0.000293	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.92e-05	0.000292	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2B6—malignant glioma	2.92e-05	0.000292	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HES1—malignant glioma	2.87e-05	0.000287	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NCOR1—malignant glioma	2.85e-05	0.000285	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—IDH2—malignant glioma	2.77e-05	0.000277	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PDGFRA—malignant glioma	2.73e-05	0.000273	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.71e-05	0.000271	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—IDH2—malignant glioma	2.7e-05	0.000271	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—IDH1—malignant glioma	2.67e-05	0.000267	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.63e-05	0.000264	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.61e-05	0.000261	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.6e-05	0.000261	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTP1—malignant glioma	2.6e-05	0.00026	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—COX8A—malignant glioma	2.59e-05	0.000259	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SPHK1—malignant glioma	2.58e-05	0.000258	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—IDH2—malignant glioma	2.55e-05	0.000255	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2B6—malignant glioma	2.54e-05	0.000254	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.53e-05	0.000253	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CAT—malignant glioma	2.53e-05	0.000253	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—IDH2—malignant glioma	2.53e-05	0.000253	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HLA-A—malignant glioma	2.51e-05	0.000251	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TERT—malignant glioma	2.51e-05	0.000251	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.49e-05	0.00025	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PDGFB—malignant glioma	2.45e-05	0.000245	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.44e-05	0.000244	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGFR1—malignant glioma	2.44e-05	0.000244	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—malignant glioma	2.42e-05	0.000242	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HIF1A—malignant glioma	2.4e-05	0.00024	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.4e-05	0.00024	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NCOR1—malignant glioma	2.39e-05	0.000239	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.39e-05	0.000239	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—IDH1—malignant glioma	2.38e-05	0.000238	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.38e-05	0.000238	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.37e-05	0.000238	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—malignant glioma	2.36e-05	0.000236	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—IDH1—malignant glioma	2.33e-05	0.000233	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.32e-05	0.000232	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CAV1—malignant glioma	2.32e-05	0.000232	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.31e-05	0.000231	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SPHK1—malignant glioma	2.31e-05	0.000231	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS1—malignant glioma	2.26e-05	0.000227	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.26e-05	0.000226	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SPHK1—malignant glioma	2.25e-05	0.000225	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS1—malignant glioma	2.21e-05	0.000221	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2C18—malignant glioma	2.2e-05	0.000221	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ASMT—malignant glioma	2.2e-05	0.00022	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—IDH1—malignant glioma	2.19e-05	0.000219	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BAD—malignant glioma	2.19e-05	0.000219	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.17e-05	0.000217	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—IDH1—malignant glioma	2.17e-05	0.000217	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOTCH1—malignant glioma	2.16e-05	0.000216	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.13e-05	0.000213	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SPHK1—malignant glioma	2.12e-05	0.000212	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CD80—malignant glioma	2.12e-05	0.000212	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.12e-05	0.000212	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APC—malignant glioma	2.12e-05	0.000212	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—BCHE—malignant glioma	2.11e-05	0.000211	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SPHK1—malignant glioma	2.1e-05	0.00021	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.1e-05	0.00021	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGF—malignant glioma	2.09e-05	0.000209	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.08e-05	0.000208	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTPN11—malignant glioma	2.08e-05	0.000208	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2C18—malignant glioma	2.08e-05	0.000208	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BCAN—malignant glioma	2.07e-05	0.000207	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.06e-05	0.000206	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—BCHE—malignant glioma	2.06e-05	0.000206	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.05e-05	0.000205	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—malignant glioma	2.05e-05	0.000205	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SLC5A5—malignant glioma	2.03e-05	0.000203	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BRAF—malignant glioma	1.99e-05	0.000199	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CAV1—malignant glioma	1.95e-05	0.000195	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.94e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.94e-05	0.000194	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT2—malignant glioma	1.94e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS1—malignant glioma	1.92e-05	0.000192	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.91e-05	0.000191	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.87e-05	0.000187	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CD—malignant glioma	1.86e-05	0.000186	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.86e-05	0.000186	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—malignant glioma	1.83e-05	0.000183	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—malignant glioma	1.78e-05	0.000178	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—BCHE—malignant glioma	1.78e-05	0.000178	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGF2—malignant glioma	1.78e-05	0.000178	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CG—malignant glioma	1.77e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.77e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.76e-05	0.000176	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.73e-05	0.000173	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS1—malignant glioma	1.71e-05	0.000171	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PPARG—malignant glioma	1.71e-05	0.000171	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.71e-05	0.000171	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.71e-05	0.000171	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—malignant glioma	1.68e-05	0.000168	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—malignant glioma	1.68e-05	0.000168	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS1—malignant glioma	1.67e-05	0.000167	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MDM2—malignant glioma	1.67e-05	0.000167	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH2—malignant glioma	1.67e-05	0.000167	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—malignant glioma	1.67e-05	0.000167	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.67e-05	0.000167	CbGpPWpGaD
Amprenavir—ABCC1—Disease—RAF1—malignant glioma	1.66e-05	0.000166	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.65e-05	0.000165	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—malignant glioma	1.64e-05	0.000164	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—malignant glioma	1.64e-05	0.000164	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CAT—malignant glioma	1.63e-05	0.000163	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CB—malignant glioma	1.62e-05	0.000162	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—malignant glioma	1.61e-05	0.000161	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAT—malignant glioma	1.59e-05	0.000159	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—BCHE—malignant glioma	1.59e-05	0.000159	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS1—malignant glioma	1.57e-05	0.000157	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.57e-05	0.000157	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.57e-05	0.000157	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS1—malignant glioma	1.56e-05	0.000156	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CD—malignant glioma	1.56e-05	0.000156	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.55e-05	0.000156	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—BCHE—malignant glioma	1.55e-05	0.000155	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NCOR1—malignant glioma	1.54e-05	0.000154	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC5A5—malignant glioma	1.53e-05	0.000153	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NCOR1—malignant glioma	1.5e-05	0.000151	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.49e-05	0.000149	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.47e-05	0.000147	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—BCHE—malignant glioma	1.46e-05	0.000146	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—BCHE—malignant glioma	1.45e-05	0.000145	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.000145	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.44e-05	0.000144	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.43e-05	0.000143	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH1—malignant glioma	1.43e-05	0.000143	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—malignant glioma	1.42e-05	0.000142	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.41e-05	0.000141	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—malignant glioma	1.4e-05	0.00014	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SPHK1—malignant glioma	1.39e-05	0.000139	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAT—malignant glioma	1.38e-05	0.000138	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CB—malignant glioma	1.36e-05	0.000136	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.36e-05	0.000136	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.36e-05	0.000136	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—malignant glioma	1.35e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.34e-05	0.000134	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NCOR1—malignant glioma	1.3e-05	0.00013	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.28e-05	0.000128	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—malignant glioma	1.27e-05	0.000127	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CAV1—malignant glioma	1.26e-05	0.000126	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—malignant glioma	1.25e-05	0.000125	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000124	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAT—malignant glioma	1.23e-05	0.000123	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAV1—malignant glioma	1.23e-05	0.000123	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAT—malignant glioma	1.2e-05	0.00012	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—malignant glioma	1.17e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.17e-05	0.000117	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—malignant glioma	1.16e-05	0.000116	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—malignant glioma	1.16e-05	0.000116	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NCOR1—malignant glioma	1.16e-05	0.000116	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—malignant glioma	1.15e-05	0.000115	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.14e-05	0.000114	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—malignant glioma	1.14e-05	0.000114	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000114	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAT—malignant glioma	1.13e-05	0.000113	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAT—malignant glioma	1.12e-05	0.000112	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.12e-05	0.000112	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARG—malignant glioma	1.1e-05	0.00011	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—malignant glioma	1.1e-05	0.00011	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARG—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOR1—malignant glioma	1.07e-05	0.000107	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAV1—malignant glioma	1.06e-05	0.000106	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOR1—malignant glioma	1.06e-05	0.000106	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS1—malignant glioma	1.03e-05	0.000103	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	0.000102	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CD—malignant glioma	1e-05	0.000101	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—malignant glioma	9.89e-06	9.89e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CD—malignant glioma	9.82e-06	9.83e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CG—malignant glioma	9.68e-06	9.68e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BCHE—malignant glioma	9.57e-06	9.57e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAV1—malignant glioma	9.48e-06	9.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.45e-06	9.45e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARG—malignant glioma	9.34e-06	9.34e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAV1—malignant glioma	9.26e-06	9.26e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.06e-06	9.06e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CB—malignant glioma	8.76e-06	8.76e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAV1—malignant glioma	8.72e-06	8.73e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—malignant glioma	8.68e-06	8.68e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAV1—malignant glioma	8.65e-06	8.65e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CG—malignant glioma	8.64e-06	8.64e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CB—malignant glioma	8.56e-06	8.57e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CD—malignant glioma	8.51e-06	8.51e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—malignant glioma	8.48e-06	8.49e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CG—malignant glioma	8.43e-06	8.44e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARG—malignant glioma	8.34e-06	8.34e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—malignant glioma	8.28e-06	8.28e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.26e-06	8.26e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARG—malignant glioma	8.14e-06	8.14e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—malignant glioma	8.08e-06	8.08e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CG—malignant glioma	7.95e-06	7.95e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.88e-06	7.88e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARG—malignant glioma	7.67e-06	7.67e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—malignant glioma	7.61e-06	7.62e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARG—malignant glioma	7.6e-06	7.61e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.59e-06	7.6e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—malignant glioma	7.57e-06	7.57e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CB—malignant glioma	7.42e-06	7.42e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CD—malignant glioma	7.41e-06	7.42e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAT—malignant glioma	7.41e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—malignant glioma	7.4e-06	7.4e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—malignant glioma	7.35e-06	7.35e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOR1—malignant glioma	7e-06	7e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CD—malignant glioma	6.98e-06	6.99e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.92e-06	6.93e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—malignant glioma	6.76e-06	6.77e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.62e-06	6.62e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—malignant glioma	6.56e-06	6.56e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CB—malignant glioma	6.46e-06	6.46e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—malignant glioma	6.41e-06	6.41e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—malignant glioma	6.4e-06	6.4e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.09e-06	6.09e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.04e-06	6.04e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—malignant glioma	6.03e-06	6.03e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—malignant glioma	5.98e-06	5.98e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—malignant glioma	5.72e-06	5.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAV1—malignant glioma	5.7e-06	5.71e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—malignant glioma	5.58e-06	5.59e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—malignant glioma	5.34e-06	5.34e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—malignant glioma	5.26e-06	5.26e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.22e-06	5.22e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—malignant glioma	5.22e-06	5.22e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.19e-06	5.2e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARG—malignant glioma	5.01e-06	5.02e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.57e-06	4.57e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.52e-06	4.52e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—malignant glioma	4.36e-06	4.36e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—malignant glioma	4.26e-06	4.27e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.04e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.98e-06	3.98e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—malignant glioma	3.94e-06	3.95e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—malignant glioma	3.94e-06	3.94e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.71e-06	3.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—malignant glioma	3.69e-06	3.69e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.68e-06	3.68e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—malignant glioma	3.44e-06	3.44e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—malignant glioma	3.3e-06	3.3e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—malignant glioma	3.22e-06	3.22e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—malignant glioma	3.03e-06	3.03e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—malignant glioma	3.01e-06	3.01e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.43e-06	2.43e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—malignant glioma	1.98e-06	1.98e-05	CbGpPWpGaD
